Few studies have investigated patient‐reported outcomes (PROs) for patients with high breast cancer risk undergoing elective risk reduction mastectomy and reconstruction. These patients incur operative risk in the absence of… Click to show full abstract
Few studies have investigated patient‐reported outcomes (PROs) for patients with high breast cancer risk undergoing elective risk reduction mastectomy and reconstruction. These patients incur operative risk in the absence of active cancer, which renders their treatment experience unique. This study aimed to identify longer‐term quality of life (QoL) issues that persist in this patient cohort.
               
Click one of the above tabs to view related content.